Cytogenetic analysis of de novo CD5-positive diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cytogenetic analysis of de novo CD5-positive diffuse large B-cell lymphoma

Published:2011-12 Issue:4 Volume:7 Page:346-350
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:

Author:

KANEKO Hiroto,SHIMURA Kazuho,HORIIKE Shigeo,KURODA Junya,MATSUMOTO Yosuke,YOKOTA Shohei,NISHIDA Koichi,OHKAWARA Yasuo,TANIWAKI Masafumi

Publisher

Wiley

Subject

Oncology,General Medicine

Reference22 articles.

1. De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients;Yamaguchi;Blood,2002

2. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;N Engl J Med,2002

3. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomized controlled trial by the MabThera International Trial (MInT) Group;Pfreundschuh;Lancet Oncol,2006

4. CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy;Ennishi;Ann Oncol,2008

5. Clinicopathologic characteristics and treatment outcome of the addition of rituximab to chemotherapy for CD5-positive in comparison with CD5-negative diffuse large B-cell lymphoma;Niitsu;Ann Oncol,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term remission after upfront autologous hematopoietic stem cell transplant for CD5 ⁺ diffuse large-B cell lymphoma;Journal of Chemotherapy;2024-04-23

2. CD5+ diffuse large B-cell lymphoma: a narrative review;Leukemia & Lymphoma;2021-07-21

3. De Novo CD5+ Diffuse Large B-Cell Lymphoma: Biology, Mechanism, and Treatment Advances;Clinical Lymphoma Myeloma and Leukemia;2020-10

4. Cytogenetics of Lymphomas;Neoplastic Diseases of the Blood;2017-09-23

5. CD5-positive follicular lymphoma characterized by CD25, MUM1, low frequency of t(14;18) and poor prognosis;Pathology International;2014-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3